ATE162716T1 - Vanadium enthaltende zusammensetzungen - Google Patents

Vanadium enthaltende zusammensetzungen

Info

Publication number
ATE162716T1
ATE162716T1 AT92920526T AT92920526T ATE162716T1 AT E162716 T1 ATE162716 T1 AT E162716T1 AT 92920526 T AT92920526 T AT 92920526T AT 92920526 T AT92920526 T AT 92920526T AT E162716 T1 ATE162716 T1 AT E162716T1
Authority
AT
Austria
Prior art keywords
compositions containing
containing vanadium
compositions
oxovanadium
monoprotic
Prior art date
Application number
AT92920526T
Other languages
English (en)
Inventor
John Hugh Mcneill
Hamid Reza Hoveyda
Chris Orvig
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Application granted granted Critical
Publication of ATE162716T1 publication Critical patent/ATE162716T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Medicinal Preparation (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92920526T 1991-09-30 1992-09-29 Vanadium enthaltende zusammensetzungen ATE162716T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/767,510 US5300496A (en) 1991-09-30 1991-09-30 Complexed vanadium for the treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
ATE162716T1 true ATE162716T1 (de) 1998-02-15

Family

ID=25079727

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92920526T ATE162716T1 (de) 1991-09-30 1992-09-29 Vanadium enthaltende zusammensetzungen

Country Status (13)

Country Link
US (1) US5300496A (de)
EP (2) EP0606318B1 (de)
JP (1) JP3515107B2 (de)
AT (1) ATE162716T1 (de)
AU (1) AU2649792A (de)
CA (1) CA2120338A1 (de)
DE (1) DE69224293T2 (de)
DK (1) DK0606318T3 (de)
ES (1) ES2112329T3 (de)
GR (1) GR3026654T3 (de)
NZ (1) NZ244569A (de)
WO (1) WO1993006811A2 (de)
ZA (1) ZA927522B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866563A (en) * 1991-09-30 1999-02-02 The University Of British Columbia Vanadium compositions
US5527790A (en) * 1991-09-30 1996-06-18 The University Of British Columbia Bis(maltolato)oxovanadium compositions for the treatment of elevated blood sugar
GB9305735D0 (en) * 1993-03-19 1993-05-05 North John R Novel agent for controlling cell activity
US5871779A (en) * 1994-01-18 1999-02-16 Mount Sinai Hospital Corporation Treatment of arthropathies with vanadate compounds or analogues thereof
US5565491A (en) * 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
US5863519A (en) * 1994-08-18 1999-01-26 Nycomed Imaging As Composition and method of MRI using both a positive and a negative contrast agent
WO1996005867A2 (en) * 1994-08-18 1996-02-29 Nycomed Imaging A/S Compositions
GB9416767D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
GB9416768D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
US5547685A (en) * 1995-05-16 1996-08-20 Eli Lilly And Company Methods for inhibiting bone loss with vanadyl sulfate
US5545661A (en) * 1995-05-16 1996-08-13 Eli Lilly And Company Methods for inhibiting bone loss with bis-pyrone oxovanadium compounds
US5885980A (en) * 1996-06-25 1999-03-23 Enrique G. Gutierrez Composition and method for treating diabetes
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
AU7022198A (en) * 1997-04-24 1998-11-24 Angiotech Pharmaceuticals, Inc. Vanadium complexes and derivatives thereof and methods related thereto
US6232340B1 (en) 1997-04-24 2001-05-15 Angiotech Pharmaceuticals, Inc. Vanadium complexes and derivatives thereof and methods related thereto
US6245808B1 (en) * 1998-11-05 2001-06-12 Parker Hughes Institute Oxy-vanadium (IV) complexes having spermicidal activity
US6432941B1 (en) * 1998-01-20 2002-08-13 Parker Hughes Institute Vanadium compounds for treating cancer
EP1113804A2 (de) * 1998-09-17 2001-07-11 Akesis Pharmaceuticals, Inc. Kombinationen des chroms oder des vanadiums mit antidiabetika für glukosemetabolismusstörungen
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
AU5613999A (en) 1998-09-18 2000-04-10 University Of British Columbia, The Pharmaceutical compositions of vanadium biguanide complexes and their use
WO2000024730A1 (en) * 1998-10-28 2000-05-04 The University Of British Columbia Organic vanadium(iii) complexes and their use
GB2396106B (en) * 2002-12-12 2006-11-15 Johnson & Johnson Medical Ltd Wound dressings comprising enzyme inhibitors
AU2005259231A1 (en) * 2004-07-02 2006-01-12 Genmedica Therapeutics Sl Arylalkylamine vanadium (V) salts for the treatment and/or prevention of diabetes mellitus
WO2006064061A1 (en) * 2004-12-16 2006-06-22 Genmedica Therapeutics Sl Amines, combination of amines and vanadium and amine vanadium salts for the treatment or prevention of dyslipidemia
US20070066682A1 (en) * 2005-07-01 2007-03-22 Exposito Miriam R Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus
US20080070987A1 (en) * 2006-05-12 2008-03-20 Francesc Yraola Font Meta-xylylenediamine vanadate salts
BR112013022907A2 (pt) 2011-03-07 2016-09-13 Cfm Pharma Holding Bv composição farmacêutica
WO2012131689A1 (en) 2011-03-25 2012-10-04 Chaudhuri Mihir K Insulin mimetic active comprising oxodiperoxo vanadates and a pharamaceutical composition obtained thereof
EP3988092B1 (de) * 2019-06-24 2026-01-28 Shenzhen Fangshengtai Medical Technology Co., Ltd. Komplexe mit oxovanadium zur verwendung in der behandlung von schmerz
CN111035652B (zh) * 2020-01-08 2021-08-24 辽宁大学 钒酸盐酪蛋白复合物在制备降糖药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1277599C (en) * 1986-10-16 1990-12-11 Barry I. Posner Vanadium - peroxide compositions as insulin mimickers
FR2619382B1 (fr) * 1987-08-11 1990-05-04 Lazaro Rene Compose organo-mineral de vanadyle, procede d'obtention d'un tel compose, composition pharmaceutique contenant ce compose organo-mineral
JPH02292217A (ja) * 1989-05-08 1990-12-03 Otsuka Pharmaceut Co Ltd 糖尿病治療薬

Also Published As

Publication number Publication date
GR3026654T3 (en) 1998-07-31
DK0606318T3 (da) 1998-09-23
ES2112329T3 (es) 1998-04-01
JPH06511244A (ja) 1994-12-15
AU2649792A (en) 1993-05-03
DE69224293D1 (de) 1998-03-05
WO1993006811A2 (en) 1993-04-15
EP0811380A3 (de) 1999-01-20
EP0811380A2 (de) 1997-12-10
EP0606318A1 (de) 1994-07-20
CA2120338A1 (en) 1993-04-15
ZA927522B (en) 1993-06-16
EP0606318B1 (de) 1998-01-28
DE69224293T2 (de) 1998-07-09
JP3515107B2 (ja) 2004-04-05
WO1993006811A3 (en) 1993-06-24
US5300496A (en) 1994-04-05
NZ244569A (en) 1995-04-27

Similar Documents

Publication Publication Date Title
ATE162716T1 (de) Vanadium enthaltende zusammensetzungen
AP2000001929A0 (en) Substituted indolealkanoic acids.
ZA975437B (en) New pyridyl alkene and pyridyl alkine acid amides.
IL92007A0 (en) Pharmaceutical compositions containing gestodene
IL159772A0 (en) Taxol enhancer compounds
MY129973A (en) Sulphonylbenzyl-substituted pyridones.
ATE259644T1 (de) Behandlung von hämoglobin enthaltenden erythrozyten mit stickstoffoxyd
GB8801306D0 (en) Chemical compounds
ATE70450T1 (de) Zusammensetzungen aus vanadium und peroxyd als nachahmungsmittel von insulin.
EP0344880A3 (en) Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer
DK0851762T3 (da) Farmaceutiske kombinationspræparater, som indeholder erythropoietin og jernpræparater
DK1057826T3 (da) Substituerede dimere carboxamidforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
ATE49749T1 (de) Aminosaeurederivate mit antitumoraktivitaet sowie diese derivate enthaltende zusammensetzungen.
ATE196768T1 (de) Neue 6-hydroxy und 6-oxo-androstan verbindungen mit kardioaktivität und pharmazeutische präparate davon
PT84564A (de) Verbindungen mit nootroper wirkung diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen
DE69519049D1 (de) Polymerisationskatalysatoren
Volpe et al. Quantitative infrared spectroscopy of CO complexes of cytochrome c oxidase, hemoglobin and myoglobin: evidence for one CO per heme
ATE199497T1 (de) Moenomycin als arzneimittel zur behandlung von magengeschwüren
DE3669713D1 (de) Alkylaminoamide und ihre salze, ihre herstellung, ihre verwendung als arzneimittel und diese verbindungen enthaltende zusammensetzungen.
DK451184A (da) 3-alkyl-7-halogen-2,3-dihydro-spiro(naphthalen-1(4h), 3'-pyrrolidin)-2',4,5'-trioner og farmaceutiske praeparater indeholdende disse
DK0688786T3 (da) Hydrazino- og hydroxyamino-14beta-hydroxyandrostanderivater med aktivitet på det cardiovaskulære system, fremgangsmåder til deres fremstilling og farmaceutiske præparater indeholdende disse.
FI902177A7 (fi) Koostumukset, jotka sisältävät elastomeereja ja karbonoimattomia, meta lleja sisältäviä komplekseja
DE3160552D1 (en) Medicine containing a biflavanone compound
IL89654A (en) Pharmaceutical combination compositions for treating hypertension
ATE339204T1 (de) Freisetzungsregulierende zubereitungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee